Obiltoxaximab

Kathryn Dzintars, PharmD, BCPS
Obiltoxaximab is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of inhalational anthrax due to Bacillus anthracis (in combination with antibacterial drugs)
  • Prevention of inhalational anthrax when alternative agents are unavailable

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of inhalational anthrax due to Bacillus anthracis (in combination with antibacterial drugs)
  • Prevention of inhalational anthrax when alternative agents are unavailable

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: June 1, 2016